Table 5.

High risk cohorts. Unadjusted incidence rates (per 1000 patient years) for end-stage renal disease, acute kidney injury and progressive chronic kidney disease. Shaded areas make up the combined reference groups.

		albumin-to-creatinine ratio (mg/g) or dipstick (classes)
		<10 Negative	10–29 trace	30–299 1+	≥300 ≥2+	All
End-Stage Renal Disease
eGFR mL/min/1.73m2	>105			1.22	6.52
	90–104	0.22		0.39	5.00	0.45
	75–89			0.30	4.56
	60–74			0.36	7.77
	45–59	0.25	0.36	1.65	13.38	1.44
	30–44	1.56	2.42	4.33	29.80	7.35
	15–29	1.57	12.78	20.93	133.0	60.98
	All	0.31		1.41	25.72	1.83
Acute Kidney Injury
eGFR mL/min/1.73m2	>105			2.99	5.54
	90–104	1.41		3.35	5.43	2.25
	75–89			3.09	9.92
	60–74			6.06	13.73
	45–59	2.28	8.00	13.42	29.03	8.07
	30–44	11.2	17.76	36.70	52.09	27.63
	15–29	25.74	48.66	69.90	104.7	73.94
	All	2.33		9.08	26.59	4.88
Progressive Chronic Kidney Disease
eGFR mL/min/1.73m2	>105			4.43	27.52
	90–104	5.51		5.75	14.44	7.97
	75–89			8.59	30.90
	60–74			19.01	68.77
	45–59	23.75	37.88	57.67	147.1	43.84
	30–44	33.55	35.35	64.99	160.3	65.65
	15–29	12.44	43.16	58.43	209.3	103.3
	All	10.40		25.96	105.0	18.44

Abbreviations are: eGFR. estimated glomerular filtration rate.